Meropeném Steriscience

Meropenem, the active ingredient in Meropeném Steriscience, is a carbapenem antibiotic presented as an injection solution for intravenous use. It treats serious bacterial infections such as sepsis, meningitis, and hospital‑acquired pneumonia in adult and pediatric patients when prescribed by a qualified healthcare professional.

GNH USA supplies Meropeném Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropeném Steriscience, a carbapenem antibiotic, is employed for infections caused by susceptible Gram‑negative and Gram‑positive bacteria.

- Complicated intra‑abdominal infections: effective treatment of infections within the abdominal cavity. - Complicated urinary tract infections: eradicates pathogens causing severe urinary infections. - Bacterial meningitis: penetrates the cerebrospinal fluid to treat central nervous system infections. - Hospital‑acquired pneumonia: combats resistant organisms in ventilated patients. - Sepsis: provides broad‑spectrum coverage for systemic bacterial infections.

Adverse reactions may occur with meropenem therapy and should be monitored.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Headache: transient discomfort. - Rash: erythematous skin eruption. - Infusion site phlebitis: pain or redness at the injection site. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Clostridioides difficile colitis: severe diarrhea due to bacterial overgrowth. - Anaphylaxis: acute, potentially life‑threatening allergic reaction. - Renal toxicity: worsening kidney function. - Thrombocytopenia: reduced platelet count. - Severe skin reactions: such as Stevens‑Johnson syndrome.

Prior to initiating therapy, consider the following safety measures.

- Renal function: adjust dosage in patients with impaired kidney function. - Allergy: avoid in individuals with known hypersensitivity to carbapenems or β‑lactams. - Seizure risk: monitor patients with a history of seizures or CNS disorders. - Pregnancy: use only when the potential benefit justifies the potential risk to the fetus. - Concurrent antibiotics: evaluate for possible antagonistic effects. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropeném Steriscience may interact with other medicines; awareness of the interaction level is essential.

Major Interactions (Avoid): - Valproic acid: reduces meropenem plasma concentrations, potentially compromising efficacy. - Phenobarbital: may lower meropenem levels, decreasing antibacterial activity.

Moderate Interactions (Monitor Closely): - Aminoglycosides: additive nephrotoxicity risk; monitor renal function. - Loop diuretics: may increase ototoxic potential when combined. - Warfarin: monitor INR as meropenem can alter anticoagulant effect.